Understanding the impact of tobacco smoking and smoking cessation on life expectancy of HIV patients in South Africa
Can't see this email? View it online
   
  HIV/AIDS HIV/AIDS logo  
  The latest HIV/AIDS news from News Medical  
 Elite Controllers: Do their genomes hold the key to curing HIV?Elite Controllers: Do their genomes hold the key to curing HIV?
 
Although South Africa has the largest number of people living with HIV worldwide, strides have been made in controlling the epidemic, especially in the reduction of HIV incidence, testing, and treatment.
 
 
 Understanding the impact of tobacco smoking and smoking cessation on life expectancy of HIV patients in South AfricaUnderstanding the impact of tobacco smoking and smoking cessation on life expectancy of HIV patients in South Africa
 
Krishna Reddy, MD, MS, a physician-investigator at the Medical Practice Evaluation Center and the Tobacco Research and Treatment Center at Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School, is the senior author of a recently published paper in Journal of the International AIDS Society: Tobacco Smoking, Smoking Cessation and Life Expectancy Among People with HIV on Antiretroviral Therapy in South...
 
   New national guidelines for anal cancer prevention in HIV patients based on UCSF researchNew national guidelines for anal cancer prevention in HIV patients based on UCSF research
 
New recommendations for screening and treatment are based on the results of a major national study led at UCSF.
 
   Llama-derived molecules target hidden strains of HIVLlama-derived molecules target hidden strains of HIV
 
A research team at Georgia State University has developed tiny, potent molecules that are capable of targeting hidden strains of HIV. The source? Antibody genes from llama DNA.
 
 Autoantibodies against type 1 interferons linked to higher susceptibility to viral disease
 
Autoantibodies against type 1 interferons linked to higher susceptibility to viral diseaseA new study shows that about two percent of the population develop autoantibodies against type 1 interferons, mostly later in life.
 
 
 Improving medication adherence beats resistance testing for better HIV outcomes in African youth
 
Improving medication adherence beats resistance testing for better HIV outcomes in African youthGlobally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa.